Skip to main content
QCLS
NASDAQ Life Sciences

Q/C Technologies Appoints OpenAI AI Systems Leader to Board with Substantial Equity Compensation

Analysis by Wiseek.ai
Sentiment info
Neutral
Importance info
8
Price
$5.62
Mkt Cap
$23.626M
52W Low
$2.5
52W High
$137.99
Market data snapshot near publication time

summarizeSummary

Q/C Technologies appointed Chelsea Voss, an AI systems leader from OpenAI, to its Board of Directors and as a consultant, granting her a significant equity and cash compensation package.


check_boxKey Events

  • New Board Appointment

    Chelsea Voss, an AI systems leader from OpenAI with key contributions to GPT-4, ChatGPT, DALL·E 2, and Codex, was appointed to the Board of Directors.

  • Consulting Agreement Executed

    Ms. Voss entered into a 12-month consulting agreement to provide services including evaluating companies, analyzing technologies, and advising on potential acquisitions.

  • Significant Equity Compensation

    The compensation package includes 212,500 restricted stock units (RSUs) and 212,500 stock options, vesting quarterly over one year. The RSU grant alone is valued at approximately $1.19 million.

  • Annual Cash Compensation

    Ms. Voss will receive a monthly fee of $12,500, totaling $150,000 annually, for her consulting services.


auto_awesomeAnalysis

Q/C Technologies, a micro-cap company focused on quantum-class computing and AI, has made a strategically important move by appointing Chelsea Voss, a key AI systems leader from OpenAI, to its Board of Directors and as a consultant. Ms. Voss's extensive experience in machine learning infrastructure and AI model development is highly relevant to the company's stated goals. However, the compensation package, which includes 212,500 restricted stock units (valued at approximately $1.19 million based on the current stock price) and 212,500 stock options, represents a substantial equity grant for a company of this size, indicating significant potential dilution for existing shareholders. This filing highlights both a strong strategic direction and a notable financial commitment.

At the time of this filing, QCLS was trading at $5.62 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $23.6M. The 52-week trading range was $2.50 to $137.99. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.

descriptionView Main SEC Filing

show_chartPrice Chart

Share this article

Copied!

feed QCLS - Latest Insights

QCLS
Apr 29, 2026, 5:19 PM EDT
Filing Type: 10-K/A
Importance Score:
9
QCLS
Apr 15, 2026, 5:20 PM EDT
Filing Type: 10-K
Importance Score:
9
QCLS
Mar 13, 2026, 4:30 PM EDT
Filing Type: 8-K
Importance Score:
8
QCLS
Feb 11, 2026, 5:17 PM EST
Filing Type: S-3
Importance Score:
8
QCLS
Jan 23, 2026, 5:00 PM EST
Filing Type: 8-K
Importance Score:
8